{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T06:34:29Z","timestamp":1792996469855,"version":"4.5.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Ventilator-associated pneumonia (VAP) results in substantial morbidity and results in high crude mortality rates. Many recent studies address multiple aspects of VAP ranging from its evolving epidemiology and microbiology to novel means for prevention and treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>The true incidence of VAP remains difficult to assess given definitional issues, which confound accurate diagnostic conclusions. The lack of a clear gold standard for identifying VAP makes comparisons across different studies difficult, as it remains unclear if like syndromes are actually being described. Nonetheless, VAP remains a clinical and costly challenge. Earlier discussion of achieving \u2018zero\u2019 VAP were clearly misplaced. Furthermore, the microbiology of VAP continues to evolve with the spread of antimicrobial resistance. New attention on the microbiome, though, may prove helpful and enhance our understanding of the pathogenesis of VAP. Simple interventions such a toothbrushing appear to successfully reduce rates of VAP and should be more broadly adopted. Rapid diagnostic tools, which are increasingly utilized to identify the causative pathogen in VAP, appear to have more limitations than previously thought. Several novel antibiotics are now available for treating multidrug-resistant organisms (MDROs) often encountered in VAP. With respect to antibiotic treatment more generally, it appears that shorter durations of therapy are well tolerated and effective, even in cases of VAP caused by MDROs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Although our knowledge and understanding of VAP continues to advance, many of the general questions of the last decade remain unresolved. We continue to lack a clear and simple means for defining VAP and have yet to identify the optimal approach for prevention. Likewise, despite the availability of newer antimicrobials, we continue to lack rapid diagnostics that can clearly be shown to improve patient-centered endpoints. The availability of newer antibiotics may allow us to more easily and safely treat MDROs, but they have not revolutionized outcomes or been shown to reduce mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mcc.0000000000001390","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T11:00:10Z","timestamp":1779447610000},"page":"443-451","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Ventilator-associated pneumonia: newer insights that can drive improved outcomes"],"prefix":"10.1097","volume":"32","author":[{"given":"Andrew F.","family":"Shorr","sequence":"first","affiliation":[{"name":"Pulmonary and Critical Care Medicine Service (AFS), Medstar Washington Hospital Center, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marya D.","family":"Zilberberg","sequence":"additional","affiliation":[{"name":"EviMed Research Group, LLC (MDZ), Goshen, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"R1-20261026","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S1473-3099(13)70081-1","article-title":"Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies","volume":"13","author":"Melsen","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"R2-20261026","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/CCM.0000000000005298","article-title":"Descriptive epidemiology and outcomes of nonventilated hospital-acquired ventilated hospital-acquired, and ventilator-associated bacterial pneumonia in the United States","volume":"50","author":"Zilberberg","year":"2022","journal-title":"Crit Care Med"},{"key":"R3-20261026","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ccm.2018.08.004","article-title":"Is zero ventilator-associated pneumonia achievable?: practical approaches to ventilator-associated pneumonia prevention","volume":"39","author":"Guillamet","year":"2018","journal-title":"Clin Chest Med"},{"key":"R4-20261026","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/QCO.0b013e3283502437","article-title":"Is a ventilator-associated pneumonia rate of zero really possible?","volume":"25","author":"Klompas","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"R5-20261026","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00134-019-05882-w","article-title":"The zero-VAP sophistry and controversies surrounding prevention of ventilator-associated pneumonia","volume":"46","author":"Colombo","year":"2020","journal-title":"Intensive Care Med"},{"key":"R6-20261026","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R7-20261026","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1017\/ice.2016.174","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention","volume":"37","author":"Weiner","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R8-20261026","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ajic.2007.04.001","article-title":"NHSN Facilities National Healthcare Safety Network (NHSN) Report, data summary for 2006, issued June 2007","volume":"35","author":"Edwards","year":"2007","journal-title":"Am J Infect Control"},{"key":"R9-20261026","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.ajic.2013.09.002","article-title":"National Healthcare Safety Network (NHSN) report, data summary for 2012. device-associated module","volume":"41","author":"Dudeck","year":"2013","journal-title":"Am J Infect Control"},{"key":"R10-20261026","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1001\/jama.2016.16226","article-title":"Trend in ventilator-associated pneumonia rates between 2005 and 2013","volume":"316","author":"Metersky","year":"2016","journal-title":"JAMA"},{"key":"R11-20261026","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/CCM.0b013e31822d7913","article-title":"A comparison of ventilator-associated pneumonia rates as identified according to the National Healthcare Safety Network and American College of Chest Physicians criteria","volume":"40","author":"Skrupky","year":"2012","journal-title":"Crit Care Med"},{"key":"R12-20261026","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1097\/CCM.0000000000000510","article-title":"Global prospective epidemiologic and surveillance study of ventilator-associated pneumonia due to Pseudomonas aeruginosa","volume":"42","author":"Kollef","year":"2014","journal-title":"Crit Care Med"},{"key":"R13-20261026","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ajic.2011.07.012","article-title":"Eight initiatives that misleadingly lower ventilator-associated pneumonia rates","volume":"40","author":"Klomas","year":"2012","journal-title":"Am J Infect Control"},{"key":"R14-20261026","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1017\/ice.2022.88","article-title":"Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 update","volume":"43","author":"Klompas","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R15-20261026","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1097\/CCM.0b013e3182a262db","article-title":"Developing a new, national approach to surveillance for ventilator-associated events","volume":"41","author":"Magill","year":"2013","journal-title":"Crit Care Med"},{"key":"R16-20261026","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s13054-016-1506-z","article-title":"Does ventilator-associated event surveillance detect ventilator-associated pneumonia in intensive care units? A systematic review and meta-analysis","volume":"20","author":"Fan","year":"2016","journal-title":"Crit Care"},{"key":"R17-20261026","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1007\/s10096-016-2703-z","article-title":"Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP\/CAP study","volume":"36","author":"Koulenti","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R18-20261026","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.ajic.2023.12.019","article-title":"International Nosocomial Infection Control Consortium (INICC) report of healthcare associated infections, data summary of 45 countries for 2015 to 2020, adult and pediatric units, device-associated module","volume":"52","author":"Rosenthal","year":"2024","journal-title":"Am J Infect Control"},{"key":"R19-20261026","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/antibiotics9020051","article-title":"Ventilator-associated tracheobronchitis: to treat or not to treat?","volume":"9","author":"Koulenti","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"R20-20261026","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1055\/s-0037-1602582","article-title":"Should we treat ventilator-associated tracheobronchitis with antibiotics?","volume":"38","author":"Martin-Loeches","year":"2017","journal-title":"Semin Respir Crit Care Med"},{"key":"R21-20261026","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1093\/cid\/ciab688","article-title":"The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections","volume":"74","author":"Baker","year":"2022","journal-title":"Clin Infect Dis"},{"key":"R22-20261026","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3390\/jcm14031000","article-title":"Ventilator-associated pneumonia in intensive care units: a comparison of pre-pandemic and COVID-19 periods","volume":"14","author":"Hlinkova","year":"2025","journal-title":"J Clin Med"},{"key":"R23-20261026","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/CCM.0000000000005498","article-title":"Etiology, treatments, and outcomes of patients with severe community-acquired pneumonia in a large U.S. sample","volume":"50","author":"Haessler","year":"2022","journal-title":"Crit Care Med"},{"key":"R24-20261026","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000007203","article-title":"Epidemiology and outcomes among adults with severe community-acquired bacterial pneumonia hospitalized in the United States","author":"Zilberberg","year":"2026","journal-title":"Crit Care Med"},{"key":"R25-20261026","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1017\/ice.2021.464","article-title":"Microbiology empiric therapy and its impact on the outcomes of nonventilated hospital-acquired, ventilated hospital-acquired, and ventilator-associated bacterial pneumonia in the United States","volume":"43","author":"Zilberberg","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R26-20261026","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1164\/rccm.200912-1853OC","article-title":"Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial","volume":"182","author":"Morrow","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"R27-20261026","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.3390\/nu14132620","article-title":"A four-probiotic regime to reduce surgical site infections in multitrauma patients","volume":"14","author":"Tzikos","year":"2022","journal-title":"Nutrients"},{"key":"R28-20261026","doi-asserted-by":"crossref","first-page":"919156","DOI":"10.3389\/fnut.2022.919156","article-title":"Probiotic supplementation prevents the development of ventilator-associated pneumonia for mechanically ventilated ICU patients: a systematic review and network meta-analysis of randomized controlled trials","volume":"9","author":"Li","year":"2022","journal-title":"Front Nutr"},{"key":"R29-20261026","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/jama.2021.13355","article-title":"Effect of probiotics on incident ventilator-associated pneumonia in critically ill patients: a randomized clinical trial","volume":"326","author":"Johnstone","year":"2021","journal-title":"JAMA"},{"key":"R30-20261026","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1186\/s13063-025-09230-w","article-title":"Probiotics to reduce ventilator-associated pneumonia in adults with acute non\u2013anoxic brain injury: study protocol for a double-blind multicenter randomized international clinical trial (PROACT)","volume":"26","author":"Corriero","year":"2025","journal-title":"Trials"},{"key":"R31-20261026","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.3390\/biomedicines13123112","article-title":"Ventilator-associated pneumonia (VAP) in neurocritical patients: the hidden dialog of brain and infection","volume":"13","author":"Rodr\u00edguez","year":"2025","journal-title":"Biomedicines"},{"key":"R32-20261026","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.2147\/CIA.S553377","article-title":"Respiratory microbiome in elderly patients on prolonged mechanical ventilation: a prospective multi-center observational study","volume":"20","author":"Wang","year":"2025","journal-title":"Clin Interv Aging"},{"key":"R33-20261026","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3390\/pathogens14111141","article-title":"Respiratory microbiome of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia: a pilot study from the Republic of Korea","volume":"14","author":"Lee","year":"2025","journal-title":"Pathogens"},{"key":"R34-20261026","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1378\/chest.116.5.1339","article-title":"A randomized clinical trial of continuous aspiration of subglottic secretions in cardiac surgery patients","volume":"116","author":"Kollef","year":"1999","journal-title":"Chest"},{"key":"R35-20261026","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1378\/chest.121.3.858","article-title":"A randomized clinical trial of intermittent subglottic secretion drainage in patients receiving mechanical ventilation","volume":"121","author":"Smulders","year":"2002","journal-title":"Chest"},{"key":"R36-20261026","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S2213-2600(25)00294-2","article-title":"Hospital and long-term outcomes for subglottic suction and polyurethane cuff versus standard endotracheal tubes in emergency intubation (PreVent 2): a randomised controlled phase 2 trial","volume":"14","author":"Treggiari","year":"2026","journal-title":"Lancet Respir Med"},{"key":"R37-20261026","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00134-018-5171-3","article-title":"Effects of chlorhexidine gluconate oral care on hospital mortality: a hospital-wide, observational cohort study","volume":"44","author":"Deschepper","year":"2018","journal-title":"Intensive Care Med"},{"issue":"8","key":"R38-20261026","first-page":"CD008367","article-title":"Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia","author":"Shi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R39-20261026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/ice.2025.54","article-title":"Evaluating the impact of an oral care initiative on the risk of nonventilator-associated hospital-acquired pneumonia using electronic clinical data and diagnostic coding surveillance criteria","volume":"46","author":"Jones","year":"2025","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R40-20261026","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1086\/678427","article-title":"Effectiveness of a dental care intervention in the prevention of lower respiratory tract nosocomial infections among intensive care patients: a randomized clinical trial","volume":"35","author":"Bellissimo-Rodrigues","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R41-20261026","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/jamainternmed.2023.6638","article-title":"Association between daily toothbrushing and hospital-acquired pneumonia: a systematic review and meta-analysis","volume":"184","author":"Ehrenzeller","year":"2024","journal-title":"JAMA Intern Med"},{"key":"R42-20261026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/ice.2025.54","article-title":"Scharfstein DO.Evaluating the impact of an oral care initiative on the risk of nonventilator-associated hospital-acquired pneumonia using electronic clinical data and diagnostic coding surveillance criteria","volume":"46","author":"Jones","year":"2025","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R43-20261026","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3390\/antibiotics14111084","article-title":"RAPID-CARE: rapid antibiotic optimization in the ICU after implementation of a pneumonia multiplex PCR test-a real-world evaluation","volume":"14","author":"Rodr\u00edguez-G\u00f3mez","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"R44-20261026","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00134-024-07772-2","article-title":"INHALE WP3, a multicentre, open-label, pragmatic randomised controlled trial assessing the impact of rapid, ICU-based, syndromic PCR, versus standard-of-care on antibiotic stewardship and clinical outcomes in hospital-acquired and ventilator-associated pneumonia","volume":"51","author":"Enne","year":"2025","journal-title":"Intensive Care Med"},{"key":"R45-20261026","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s13054-025-05428-1","article-title":"Cost-effectiveness of rapid, ICU-based, syndromic PCR in hospital-acquired pneumonia: analysis of the INHALE WP3 multicentre RCT","volume":"29","author":"Wagner","year":"2025","journal-title":"Crit Care"},{"key":"R46-20261026","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s13054-025-05623-0","article-title":"Impact of syndromic molecular diagnostics on antimicrobial adequacy and time to therapy in critically ill patients with pneumonia: a systematic review and meta-analysis of randomized trials","volume":"29","author":"de Albuquerque Pessoa Dos Santos","year":"2025","journal-title":"Crit Care"},{"key":"R47-20261026","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S2213-2600(23)00418-6","article-title":"Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised, open-label, noninferiority trial","volume":"12","author":"Mo","year":"2024","journal-title":"Lancet Respir Med"},{"key":"R48-20261026","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/QCO.0000000000000712","article-title":"Novelty and nuance in the intensive care unit: new options to combat multidrug resistant pneumonia","volume":"34","author":"Shorr","year":"2021","journal-title":"Curr Opin Infect Dis"},{"key":"R49-20261026","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/jama.2024.9779","article-title":"Continuous vs intermittent \u03b2-lactam antibiotic infusions in critically ill patients with sepsis: the BLING III Randomized Clinical Trial","volume":"332","author":"Dulhunty","year":"2024","journal-title":"JAMA"},{"key":"R50-20261026","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1001\/jama.2024.9803","article-title":"Prolonged vs intermittent infusions of \u03b2-lactam antibiotics in adults with sepsis or septic shock: a systematic review and meta-analysis","volume":"332","author":"Abdul-Aziz","year":"2024","journal-title":"JAMA"}],"container-title":["Current Opinion in Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MCC.0000000000001390","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T06:00:24Z","timestamp":1792994424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MCC.0000000000001390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mcc.0000000000001390","relation":{},"ISSN":["1070-5295","1531-7072"],"issn-type":[{"value":"1070-5295","type":"print"},{"value":"1531-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]}}}